Brain biopterin and tyrosine hydroxylase in asymptomatic dopa-responsive dystonia

被引:25
作者
Furukawa, Y [1 ]
Kapatos, G
Haycock, JW
Worsley, J
Wong, H
Kish, SJ
Nygaard, TG
机构
[1] Ctr Addict & Mental Hlth, Clarke Div, Movement Disorders Res Lab R211, Toronto, ON M5T 1R8, Canada
[2] Ctr Addict & Mental Hlth, Clarke Div, Human Neurochem Pathol Lab, Toronto, ON M5T 1R8, Canada
[3] Wayne State Univ, Sch Med, Dept Psychiat & Behav Neurosci, Detroit, MI USA
[4] Louisiana State Univ, Ctr Hlth Sci, Dept Biochem & Mol Biol, New Orleans, LA USA
[5] E Orange Vet Affairs Med Ctr, Dept Neurol, E Orange, NJ USA
[6] Univ Med & Dent New Jersey, Sch Med, Dept Neurosci, Newark, NJ 07103 USA
关键词
D O I
10.1002/ana.10175
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
It is assumed that brain biopterin and dopamine loss should not be as severe in asymptomatic dopa-responsive dystonia caused by GCH1 mutations as it is in symptomatic dopa-responsive dystonia. However, the actual status of dopaminergic systems in asymptomatic cases is unknown. In the autopsied putamen of an asymptomatic GCH1 mutation carrier, we found that brain biopterin loss (-82%) paralleled that reported in dopa-responsive dystonia patients (-84%). However, tyrosine hydroxylase protein and dopamine levels (-52 and -44%, respectively) were not as severely affected as in symptomatic patients (exceeding -97 and -88%, respectively). Our data suggest that the extent of striatal tyrosine hydroxylase protein loss may be critical in determining doparesponsive dystonia symptomatology.
引用
收藏
页码:637 / 641
页数:5
相关论文
共 21 条
[1]
Reduced lymphoblast neopterin detects GTP cyclohydrolase dysfunction in dopa-responsive dystonia [J].
Bezin, L ;
Nygaard, TG ;
Neville, JD ;
Shen, H ;
Levine, RA .
NEUROLOGY, 1998, 50 (04) :1021-1027
[2]
ANALYSIS OF REDUCED FORMS OF BIOPTERIN IN BIOLOGICAL TISSUES AND FLUIDS [J].
FUKUSHIMA, T ;
NIXON, JC .
ANALYTICAL BIOCHEMISTRY, 1980, 102 (01) :176-188
[3]
Gender-related penetrance and de novo GTP-cyclohydrolase I gene mutations in dopa-responsive dystonia [J].
Furukawa, Y ;
Lang, AE ;
Trugman, JM ;
Bird, TD ;
Hunter, A ;
Sadeh, M ;
Tagawa, T ;
St George-Hyslop, PH ;
Guttman, M ;
Morris, LW ;
Hornykiewicz, O ;
Shimadzu, M ;
Kish, SJ .
NEUROLOGY, 1998, 50 (04) :1015-1020
[4]
Dystonia with motor delay in compound heterozygotes for GTP-cyclohydrolase I gene mutations [J].
Furukawa, Y ;
Kish, SJ ;
Bebin, EM ;
Jacobson, RD ;
Fryburg, JS ;
Wilson, WG ;
Shimadzu, M ;
Hyland, K ;
Trugman, JM .
ANNALS OF NEUROLOGY, 1998, 44 (01) :10-16
[5]
Striatal biopterin and tyrosine hydroxylase protein reduction in dopa-responsive dystonia [J].
Furukawa, Y ;
Nygaard, TG ;
Gütlich, M ;
Rajput, AH ;
Pifl, C ;
DiStefano, L ;
Chang, LJ ;
Price, K ;
Shimadzu, M ;
Hornykiewicz, O ;
Haycock, JW ;
Kish, SJ .
NEUROLOGY, 1999, 53 (05) :1032-1041
[6]
Furukawa Y, 1999, MOVEMENT DISORD, V14, P709, DOI 10.1002/1531-8257(199909)14:5<709::AID-MDS1001>3.0.CO
[7]
2-T
[8]
Dope-responsive dystonia simulating spastic paraplegia due to tyrosine hydroxylase (TH) gene mutations [J].
Furukawa, Y ;
Graf, WD ;
Wong, H ;
Shimadzu, M ;
Kish, SJ .
NEUROLOGY, 2001, 56 (02) :260-263
[9]
Furukawa Y, 2000, ANN NEUROL, V47, P517
[10]
Biochemical aspects of Parkinson's disease [J].
Hornykiewicz, O .
NEUROLOGY, 1998, 51 (02) :S2-S9